Anesthesia care in the United States is provided by a number of different practice models, that could involve nurses, physician’s assistants, and physicians working in teams or alone. Much of the variation in care models evolved over time based on...
Anesthesia care in the United States is provided by a number of different practice models, that could involve nurses, physician’s assistants, and physicians working in teams or alone. Much of the variation in care models evolved over time based on...
Anesthesia care in the United States is provided by a number of different practice models, that could involve nurses, physician’s assistants, and physicians working in teams or alone. Much of the variation in care models evolved over time based on...
Type 2 diabetes (T2D) and non-small cell lung cancer (NSCLC) each represent costly chronic diseases with substantial public health implications. A better understanding of the relationship between T2D treatments and NSCLC has many important implica...
Type 2 diabetes (T2D) and non-small cell lung cancer (NSCLC) each represent costly chronic diseases with substantial public health implications. A better understanding of the relationship between T2D treatments and NSCLC has many important implica...
Type 2 diabetes (T2D) and non-small cell lung cancer (NSCLC) each represent costly chronic diseases with substantial public health implications. A better understanding of the relationship between T2D treatments and NSCLC has many important implica...
Specialty medications are medications that require special manufacturing and distribution processes and usually for the treatment of rare diseases and conditions. As a result of the low volume of use and high overhead associated with manufacturing...
Specialty medications are medications that require special manufacturing and distribution processes and usually for the treatment of rare diseases and conditions. As a result of the low volume of use and high overhead associated with manufacturing...
ABSTRACTSHWETA SHAH. Survival, healthcare utilization and costs associated with chronic obstructive pulmonary disease among SEER-Medicare beneficiaries with non-small cell lung cancer. (Under the direction of DR. CHRISTOPHER M. BLANCHETTE)Lung can...
ABSTRACTSHWETA SHAH. Survival, healthcare utilization and costs associated with chronic obstructive pulmonary disease among SEER-Medicare beneficiaries with non-small cell lung cancer. (Under the direction of DR. CHRISTOPHER M. BLANCHETTE)Lung can...
ABSTRACTSHWETA SHAH. Survival, healthcare utilization and costs associated with chronic obstructive pulmonary disease among SEER-Medicare beneficiaries with non-small cell lung cancer. (Under the direction of DR. CHRISTOPHER M. BLANCHETTE)Lung can...
